Thomas N. Chase
Oprichter bij Chase Therapeutics Corp.
Actieve functies van Thomas N. Chase
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Chase Therapeutics Corp.
 Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chase Therapeutics Corp. operates as healthcare company. The company was founded in 2017 and is headquartered in Washington, DC. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - | |
| Oprichter | - | - | |
| President | - | - |
Loopbaan van Thomas N. Chase
Eerdere bekende functies van Thomas N. Chase
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Hamilton Pharmaceuticals, Inc.
 Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Hamilton Pharmaceuticals, Inc. develops and supplies pharmaceuticals. It also develops and commercializes novel medical treatments for central nervous system disease. The company was founded in April 2004 and is headquartered in Washington, DC. | Directeur/Bestuurslid | 01-01-2005 | 01-01-2007 |
| Algemeen Directeur | 01-01-2005 | 01-01-2007 | |
| President | 01-01-2005 | 01-01-2007 | |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Directeur/Bestuurslid | 01-01-2007 | - |
| Algemeen Directeur | 01-01-2007 | 12-05-2014 | |
| Hoofd Techniek/Wetenschap/O&O | 12-05-2014 | - | |
| Oprichter | 01-01-2007 | - | |
| Investor Relations Contact | 26-06-2013 | 12-05-2014 | |
| Public Communications Contact | 26-06-2013 | 12-05-2014 | |
| National Institute of Neurological Disorders & Stroke | Hoofd Techniek/Wetenschap/O&O | - | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Opleiding van Thomas N. Chase
| Massachusetts Institute of Technology | Undergraduate Degree |
| Yale University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| President | 2 |
Sectoraal
| Government | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Hamilton Pharmaceuticals, Inc.
Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Hamilton Pharmaceuticals, Inc. develops and supplies pharmaceuticals. It also develops and commercializes novel medical treatments for central nervous system disease. The company was founded in April 2004 and is headquartered in Washington, DC. | Commercial Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
| National Institute of Neurological Disorders & Stroke | Government |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Health Technology |
Chase Therapeutics Corp.
Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chase Therapeutics Corp. operates as healthcare company. The company was founded in 2017 and is headquartered in Washington, DC. | Health Technology |
- Beurs
- Insiders
- Thomas N. Chase
- Ervaring
